CAMBRIDGE COGNITION HOLDINGS PLC
COG | IL
Overview
Corporate Details
- ISIN(s):
- GB00B8DV9647 (+2 more)
- LEI:
- 213800SZKDIN122EPA96
- Country:
- United Kingdom
- Address:
- TUNBRIDGE COURT, TUNBRIDGE LANE, BOTTISHAM, CB25 9TU CAMBRIDGE
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cambridge Cognition Holdings PLC is a neuroscience technology company specializing in digital solutions for assessing brain health. The company provides an end-to-end platform for Central Nervous System (CNS) clinical trials, designed to accelerate drug development and enhance research. Its portfolio of technologies includes scientifically validated digital cognitive assessments (such as its flagship CANTAB® product), voice analysis, electronic questionnaires, and a comprehensive platform for decentralized clinical trials. With over 30 years of scientific validation, its highly sensitive tools enable precise measurement of cognitive changes in-clinic or at home. The company serves leading pharmaceutical organizations, academic research institutions, and healthcare professionals globally, with expertise across numerous therapeutic areas including Alzheimer's disease, depression, and schizophrenia.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for CAMBRIDGE COGNITION HOLDINGS PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-28 08:01 |
Board/Management Information
Changes to Board and Management
|
English | 29.4 KB | |
| 2025-08-19 11:10 |
Regulatory News Service
Monument Therapeutics Partnership with FNIH
|
English | 30.9 KB | |
| 2025-08-12 08:00 |
Earnings Release
Launch of Speaker Identification Solution
|
English | 26.7 KB | |
| 2025-07-31 08:00 |
Earnings Release
Trading update for period ended 30 June 2025
|
English | 22.4 KB | |
| 2025-06-27 13:27 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 31.6 KB | |
| 2025-06-04 08:00 |
Report Publication Announcement
Notice of AGM
|
English | 14.4 KB | |
| 2025-05-06 18:59 |
Major Shareholding Notification
Holding(s) in Company
|
English | 24.2 KB | |
| 2025-03-06 08:00 |
Legal Proceedings Report
CANTAB® used for major global brain health study
|
English | 24.2 KB | |
| 2025-02-18 08:00 |
Legal Proceedings Report
Cambridge Cognition submits FDA Letter of Intent
|
English | 18.9 KB | |
| 2025-02-07 08:00 |
Board/Management Information
Board Appointment
|
English | 19.4 KB | |
| 2025-01-21 08:00 |
Earnings Release
Launch of in-house rater training service
|
English | 17.5 KB | |
| 2025-01-16 08:00 |
Environmental & Social Information
Expanded partnership with Actinogen
|
English | 20.3 KB | |
| 2025-01-08 08:00 |
Regulatory News Service
CANTAB® success in Bristol Myers Squib research
|
English | 17.4 KB | |
| 2024-12-27 16:34 |
Director's Dealing
Director/PDMR Share Purchases
|
English | 22.6 KB | |
| 2024-12-23 17:02 |
Director's Dealing
Director/PDMR Share Purchases
|
English | 22.9 KB |
Automate Your Workflow. Get a real-time feed of all CAMBRIDGE COGNITION HOLDINGS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for CAMBRIDGE COGNITION HOLDINGS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
